EP 1185642 A2 20020313 - COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR
Title (en)
COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR
Title (de)
ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON TUMOREN
Title (fr)
COMPOSITIONS ET METHODES DE TRAITEMENT DE TUMEUR
Publication
Application
Priority
- US 0013358 W 20000515
- US 13838599 P 19990609
- US 14479099 P 19990720
- US 14684399 P 19990803
- US 14818899 P 19990810
- US 14932099 P 19990817
- US 14932799 P 19990817
- US 14939699 P 19990817
- US 15011499 P 19990820
- US 15170099 P 19990831
- US 15173499 P 19990831
Abstract (en)
[origin: EP1683811A2] The invention concerns compositions and methods for the diagnosis and treatment of neoplastic cell growth and proliferation in mammals, including humans. The invention is based upon the identification of genes that are amplified in the genome of tumor cells. Such gene amplification is expected to be associated with the overexpression of the gene product as compared to normal cells of the same tissue type and contribute to tumorigenesis. Accordingly, the proteins encoded by the amplified genes are believed to be useful targets for the diagnosis and/or treatment (including prevention) of certain cancers, and may act as predictors of the prognosis of tumor treatment. The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
IPC 1-7
C12N 15/12; C07K 14/47; C07K 16/18; G01N 33/53; A61K 38/17; C12N 15/11; C12N 15/62
IPC 8 full level
G01N 33/50 (2006.01); A61K 31/7088 (2006.01); A61K 38/17 (2006.01); A61K 39/395 (2006.01); A61K 45/00 (2006.01); A61K 48/00 (2006.01); A61P 35/00 (2006.01); C07K 14/47 (2006.01); C07K 16/18 (2006.01); C07K 16/42 (2006.01); C07K 19/00 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); C12N 15/11 (2006.01); C12N 15/12 (2006.01); C12N 15/13 (2006.01); C12N 15/62 (2006.01); C12P 21/02 (2006.01); C12P 21/08 (2006.01); C12Q 1/02 (2006.01); C12Q 1/68 (2006.01); G01N 33/15 (2006.01); G01N 33/53 (2006.01); G01N 33/566 (2006.01)
CPC (source: EP)
A61P 1/00 (2018.01); A61P 11/00 (2018.01); A61P 35/00 (2018.01); A61P 43/00 (2018.01); C07K 14/4748 (2013.01); G01N 33/57484 (2013.01)
Citation (examination)
- WO 9914327 A2 19990325 - GENENTECH INC [US], et al
- WO 9927100 A1 19990603 - GENENTECH INC [US], et al
- COLLINS V.: "Gene amplification in human gliomas", GLIA, vol. 15, no. 3, November 1995 (1995-11-01), pages 289 - 296, XP002109702
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0075317 A2 20001214; WO 0075317 A3 20010208; AT E440109 T1 20090915; AT E444971 T1 20091015; AU 4851900 A 20001228; CA 2371434 A1 20001214; DE 60042799 D1 20091001; DE 60043125 D1 20091119; EP 1185642 A2 20020313; EP 1657256 A2 20060517; EP 1657256 A3 20060809; EP 1657256 B1 20091007; EP 1683811 A2 20060726; EP 1683811 A3 20061011; EP 1683811 B1 20090819; ES 2331657 T3 20100112; ES 2332916 T3 20100215; JP 2003501087 A 20030114; JP 2005027667 A 20050203; JP 2006006330 A 20060112; JP 2006006331 A 20060112; JP 2006006332 A 20060112; JP 4252501 B2 20090408; JP 4260778 B2 20090430
DOCDB simple family (application)
US 0013358 W 20000515; AT 05024729 T 20000515; AT 06001196 T 20000515; AU 4851900 A 20000515; CA 2371434 A 20000515; DE 60042799 T 20000515; DE 60043125 T 20000515; EP 00930756 A 20000515; EP 05024729 A 20000515; EP 06001196 A 20000515; ES 05024729 T 20000515; ES 06001196 T 20000515; JP 2001502580 A 20000515; JP 2004186386 A 20040624; JP 2005181534 A 20050622; JP 2005181558 A 20050622; JP 2005181588 A 20050622